Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.86
-$0.55 (-4.10%)
At close: Oct 30, 2026, 4:00 PM ET
$12.86
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 160.27M |
Short-Term Investments | 385.79M |
Long-Term Investments | 106.67M |
Other Long-Term Assets | 15.67M |
Receivables | 2.73M |
Inventory | n/a |
Other Current Assets | 1.23M |
Total Current Assets | 557.54M |
Property-Plant & Equipment | 12.42M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 134.76M |
Total Assets | 692.29M |
Account Payables | 7.53M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 9.97M |
Total Current Liabilities | 46.41M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 992.63M |
Total Long-Term Liabilities | 1B |
Total Liabilities | 1.05B |
Total Debt | 10.75M |
Book Value | -356.46M |
Book Value Per Share | -3.02 |
Common Stock | n/a |
Retained Earnings | -368.67M |
Comprehensive Income | 229K |
Shareholders Equity | -356.46M |
Total Investments | 492.46M |
Add to Watchlist
Select watchlists to add or remove KLRA